Maintenance will be taking place on BSI Shop and standards catalogue Wednesday 22 March 2017 between 17:00 – 23:00 GMT. BSI Shop will be unavailable during this time.  Please accept our apologies for any inconvenience caused during this essential maintenance work. Please come back later and try again.

Major multiple sclerosis regenerative medicine trial announced

01 August 2011


Posted by Michelle Devonshire

A significant clinical trial is looking into the use of stem cells in the treatment of multiple sclerosis (MS).

The experiment will involve 150 to 200 individuals around the world, examining ways in which regenerative medicine could be employed to reverse damage to the spinal cord and brain caused by the condition.

It will take the form of a major clinical trial aimed at finding out whether stem cells can be used safely in the treatment of patients with MS, with funding provided jointly by the UK Stem Cell Foundation and the MS Society.

"Stem cells hold tremendous potential as a future treatment option for people with MS," Chief Executive of the MS Society, Simon Gillespie, declared.

Through the programme, stem cells will be taken from individuals' bone marrow, cultivated in laboratories and re-injected in a bid to stall or reverse damage as a result of MS.

In related news, scientists at the University of Glasgow and the University of Southampton have been employing nanotechnology in order to enhance the processes employed to grow stem cells by creating a nano-patterned plastic surface.

 Your basket
Your basket is empty